Synthesis and structure-activity relationship studies of substituted isoquinoline analogs as antitumor agent

Archives of Pharmacal Research

Volumn 21, Issue 2, 1998, Pages 193-197

  Cheon, Seung Hoon ^a   Park, Joon Suck ^a   Chung, Byung Ho ^a   Choi, Bo Gil ^a   Cho, Won Jea ^a   Choi, Sang Un ^b   Lee, Chong Ock ^b  

^a Chonnam National University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Antitumor; Bioisostere; Isoquinolin 1 ones

Indexed keywords

ANTINEOPLASTIC AGENT; ISOQUINOLINE DERIVATIVE;

ARTICLE; CELL CULTURE; DRUG SCREENING; HUMAN; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; ISOQUINOLINES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0032035119     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02974027     Document Type: Article

References (20)

1. Berdel, W. E. and Munder, P. G., Antitumor Analogs of PAF, In Snyder, F. (Ed). Platelet-Activating Factor and Related Lipid Mediators. Plenum Press, New York, pp. 449-467, 1987.
2. Brunton, V. G., Workman, P., Br. J, Cancer, 67, 989 (1993).
3. Cheon, S. H., Park, J. S., Jeong, S. H., Chung, B. H., Choi, B. G., Cho, W. J., Kang, B. H., Lee, C. O., Synthesis and Structure-Activity Relationship Studies of 2,3-Dihydroimidazo[2,1-a]isoquinoline Analogs as Antitumor Agents. Arch. Pharm. Res., 20, 138-143 (1997).
4. Cho, W. J., Yoo, S. J., Chung, B. H., Choi, B. G., Cheon, S. H., Whang, S. H., Kim, S. K., Kang, B. H., Lee, C. O., Synthesis of Benzo[c]phenanthridine Derivatives and their in vitro Antitumor Activities. Arch. Pharm. Res., 19, 321-325 (1996).
5. Danhauser-Riedl, S., Felix, S. B., Houlihan, W. J., Zafferani, M., Steinhauser, G., Oberberg, D., Kalvelage, H., Busch, R., Rastetter, J., Berdel, W. F., Cancer Res., 51, 43 (1991).
6. Dive, C., Watson, J. V. and Workman, P., Multiparametric Flow Cytometry of the Modulation of Tumor Cell Membrane Permeability by Developmental Antitumor Ether Lipid SRI 62-834 in EMT6 Mouse Mammary Tumor and HL6O Human Promyelocytic Leukemia cells. Cancer Res., 51, 799-806 (1990).
7. Houlihan, W. J. and Parrino, V. A., Directed Lithiation of 2-Phenyl- and 2-(o-methylphenyl)imidazoline. J. Org. Chem., 47, 5177-5180 (1982).
8. Houlihan, W. J., Cheon, S. H., Parrino, V. A., Handley, D. A. and Larson, D. A., Structural Modification of 5-Aryl-2,3-dihydroimidazo[2,1-a]isoquinoline Platelet Activating Factor Receptor Antagonists. J. Med. Chem., 36, 3098-3102 (1993).
9. Houlihan, W. J., Munder, P. G., Handley, D. A., Cheon, S. H. and Parrino, V. A., Antitumor Activity of 5-Aryl-2,3-dihydroimidazo[2,1-a]isoquinolines. J. Med. Chem., 38, 234-240 (1995a).
10. Houlihan, W. J., Munder, P. G., Handley, D. A. and Nemecek, G. A., Priclinical Pharmacology and Possible Mechanism of Action of the Novel Antitumor Agent 5-(4′-Piperidinomethylphenyl)-2,3-dihydroimidazo[2,1-a]isoquinoline. Arzneim.-Forsch./Drug Res., 45(II), 1133-1137 (1995c).
11. Modest, E. J., Berens, M. E., Piantadosi, C. and Noseda, A., Pharmacological Effects and Anticancer Activity of New Ether Phospholipid Analogs, In Kabara J. J. (Ed). The Pharmacological Effect of lipids III, Role of Lipids in Cancer Research. The American Oil Chemists' Society, Champaign, IL, pp. 330-337, 1989.
12. Munder, P. G. and Westphal, O., Antitumoral and Other Biomedical Activities of Synthetic Ether Lysophospholipids, In Waksman, B. H. (Ed). 1939-1989: Fifty Years Progress in Allergy. Karger, New York, pp. 206-235, 1990.
13. Noseda, A., Godwin, P. L and Modest, E. J., Effects of Antineoplastic Ether Lipids on Model and Biological Membranes. Biochim. Biophys. Acta, 945, 92-100 (1988).
14. Poindexter, G. S., J. Org. Chem., 47, 3787-3788 (1982).
15. Rubinstein, L. V., Shoemaker, R. H., Paul, K. D., Simon, R. M., Tosini, S., Skehan, P., Scudiero, D., Monks, A., and Boyd, M. R., J. Natl. Cancer Inst., 82, 1113 (1990).
16. 2+ Signaling by Antitumor Ether Lipid Analogues, Cancer Res., 50, 4458-4463 (1990).
17. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J. B., Vistica, D. T., Warren, J. T., Bokesch, H., Kenny, S., and Boyd, M. R., J. Natl. Cancer Inst., 82, 1107 (1990).
18. Still, W. C., Kahn, M., Mitra, A. J., J. Org. Chem., 43, 2923 (1978).
19. Uberall, F., Oberhuber, H., Maly, K., Zaknun J., Demuth, L. and Grunicke, H. H., Hexadecylphosphocholine Inhibits Inositol Phosphate Formation and Protein Kinase C Activity. Cancer Res., 51, 807-812 (1991).
20. Workman, P., Antitumor Ether Lipids: Endocytosis as a Determination of Cellular Sensitivity. Cancer Cells, 3, 315-317 (1991).